Editorial: Frontiers' Research Topic "Cancer Vaccines: Time to Think Differently!"

Front Immunol. 2021 Oct 15:12:771319. doi: 10.3389/fimmu.2021.771319. eCollection 2021.

Stephanie E B McArdle^{1

2}, Graham Pawelec^{3

4}, Alan Graham Pockley^{1

2}, Pål Johansen⁵

¹ John Van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, United Kingdom.
² Centre for Health, Ageing and Understanding Disease (CHAUD), School of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom.
³ Department of Immunology, Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany.
⁴ Cancer Solutions Program, Health Sciences North Research Institute (HSNRI), Sudbury, ON, Canada.
⁵ Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.

No abstract available

Keywords: PD1 and PDL1; cancer vaccine combination; combined immunotherapies; dendritic cells; novel approach.

Publication types